Fig. 1: Therapy strategy with DC/tumor fusion+LPS-Nb36 treatment.

DC-tumor fusion vaccine were first generated. Then, the Nb36/liposome complex eliminated immunosuppression via blocking CTLA-4-mediated negative co-stimulation in the CD8⁺ T cells stimulated by DC/tumor fusion vaccine.